{
    "paper_id": "PMC7096936",
    "metadata": {
        "title": "Reviews and comment from the nature publishing group",
        "authors": []
    },
    "body_text": [
        {
            "text": "\u25cfThe NKT cell system: bridging innate and acquired immunity. Taniguchi, M., Seino, K. I. & Nakayama, T. Nature Immunology December (2003).",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "\u25cfHIV-1 dynamics \nin vivo\n: implications for therapy. Simon, V. & Ho, D. D. Nature Reviews Microbiology December (2003).",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "\u25cfA reprint supplement on RNAi will be distributed with the December issues of \nNature Reviews Molecular Cell Biology, Nature Reviews Drug Discovery\n and \nNature Reviews Genetics. The supplement \u2014 sponsored by Qiagen \u2014 contains six highlights, four reviews and a perspective, and is accompanied by a free web focus (http://www.nature.com/reviews/focus.rnai)",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "\u25cfThe immune response of \nDrosophila. Hoffmann, J. A. Nature 6 November (2003).",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "\u25cfJAKing up immunosuppression. Sykes, M. Nature Medicine December (2003). Discussion of a recent study in Science reporting a new immunosuppressive agent that specifically targets cytokine signalling through JAK3 in a primate model of kidney transplantation.",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "\u25cfAutoimmunity heats up. Gelman, A. E. & Turka, L. A. Nature Medicine December (2003). This News & Views article discusses the role of heat-shock proteins in activating the immune system after a study showing that Hsp70 can trigger autoimmunity in a mouse model of diabetes.",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "\u25cfSARS \u2014 beginning to understand a new virus. Stadler, K. et al. Nature Reviews Microbiology December (2003). This review looks at the genomics, phylogeny and antigen structure of the SARS-Coronavirus (SARS-CoV), together with the immune response to it and potential therapeutic interventions.",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "\u25cfAdjuvants and their signalling pathways: beyond TLRs. Lien, E. & Golenbock, D. T. Nature Immunology December (2003). Microbial molecules that are ligands for TLRs, such as lipopolysaccharide (LPS) and poly(I:C), can act as adjuvants by enhancing the immune response to other antigens. This News & Views article looks at the different signalling pathways induced by LPS and poly(I:C) and their dependence on the adaptor protein TRIF/TICAM1.",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "\u25cfFresh assualt on hepatitis C. Rice, C. M. Nature 13 November (2003). Following on from the success of protease inhibitors in suppressing HIV replication, this News & Views article discusses recent promising trials of a drug that blocks a hepatitis C virus protease that is essential for replication. The drug BILN 2061 was found to cause a more rapid decrease in viral load than the present preferred therapy of interferon administration.",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        }
    ],
    "ref_entries": {},
    "back_matter": [],
    "bib_entries": {}
}